Back to Search
Start Over
The EORTC 10041/BIG 03-04 MINDACT trial is feasible: results of the pilot phase.
- Source :
- European journal of cancer, 47 (18
- Publication Year :
- 2011
-
Abstract
- The MINDACT (Microarray In Node-negative and 1-3 node positive Disease may Avoid ChemoTherapy) trial investigates the clinical utility of the 70-gene profile (MammaPrint) for the selection of breast cancer patients for adjuvant chemotherapy (CT) together with standard clinicopathological criteria. We present the results of the pilot phase consisting of first 800 patients included.<br />Journal Article<br />Multicenter Study<br />Randomized Controlled Trial<br />Research Support, N.I.H. Extramural<br />Research Support, Non-U.S. Gov't<br />SCOPUS: ar.j<br />info:eu-repo/semantics/published
Details
- Database :
- OAIster
- Journal :
- European journal of cancer, 47 (18
- Notes :
- Rutgers, Emiel, Piccart-Gebhart, Martine, Bogaerts, Jan, Delaloge, Suzette, Van't Veer, Laura, Rubio, Isabel Teresa, Viale, Giuseppe, Thompson, Alastair, Passalacqua, Rodolfo, Nitz, Ulrike, Vindevoghel, Anita, Pierga, Jean-Yves, Ravdin, Peter, Werutsky, Gustavo, Cardoso, Fatima
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.ocn812601623
- Document Type :
- Electronic Resource